Copyright
©The Author(s) 2022.
World J Clin Cases. Aug 16, 2022; 10(23): 8312-8322
Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8312
Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8312
Ref. | Age (yr) | Symptom | Past history | Immunophenotype (+) | Location | Maximum diameter (cm) | Imaging examination | Lymphadenopathy | Type (FAB classification) | Treatment | Follow-up |
Kamble et al[15], 1997 | 33 | Hypermenorrhea, pain and fever | NS | NS | The vagina fornix and the cervix | 7.0 | US: A hypoechoic mass extending posteriorly to the vagina and bilateral dilated lower end of ureter. | NS | M2 | Symptomatic treatment | Died (renal failure and fungaemia) |
Unterweger et al[12], 2002 | 30 | Vaginal bleeding, vaginal mass and fatigue | NS | MPO, lysozyme, CEA | The vaginal fornix and the cervix | 5.0 | MRI: A large tumor on the anterior vaginal wall extending to the cervix, suspected infiltration of the urinary bladder; CT: A homogeneous tumor appears in the the vagina, cannot be separated from the cervix; US: A homogeneous, predominantly solid space requirement of the anterior vaginal wall | The mediastinal LN | M5 | Chemo | CR |
Imagawa et al[6], 2010 | 25 | Stinking vaginal discharge | NS | Lysozyme, CD68, CD34 | The rectovaginal septum and the vaginal cavity | 7.9 | MRI: A large solitary tumor located in the vagina; PET/CT: The vaginal tumor demonstrated an increased FDG uptake with a SUV of 7.6 | NS | M2 | Chemo | CR, 3 y |
Skeete et al[7],2010 | 77 | Vaginal mass, urinary incontinence and fatigue | No | MPO, CD68, CD43, CD45 | The vaginal wall | NS | CT: A mass involving the vagina extending to the cervix with thickening of the vaginal wall | No | Isolated MS | Chemo, RT | Died (condition deteriorated and dyspnea) |
Qiang et al[14], 2010 | 52 | Vaginal mass | Isolated MS in the cervix reached CR with chemo and hysterectomy 11 yr ago | MPO, CD117 | The vaginal stump | 8.0 | MRI: A pear-shaped homogeneous mass arising from the vaginal stump | NS | Isolated MS | Chemo | Died (sepsis) |
Nazer et al[8], 2012 | 41 | Vaginal mass | AML (M5) reached CR 10 mo ago | MPO, CD117, CD43 | The vulva, the vaginal and adjacent cervix | NS | MRI: Intermediate signal intensity mass surrounding the vagina, cervix and urethra with intact fibrous stromal tissue, invading the parametrium with involvement of the labia minora. | NS | Isolated MS | Chemo, RT | CR, 8 mo (multiple site relapse) |
Modi et al[9], 2015 | 68 | Vaginal bleeding | No | MPO, CD117, LCA | The vaginal fornix and vaginal wall | 6.0 | CT: Well-defined homogenously enhancing lesion arising from the left side of the vagina, projecting into vaginal lumen | NS | Isolated MS | Chemo | Asymptomatic |
Yuan et al[11], 2015 | 40 | Vaginal bleeding and vaginal mass | No | MPO, CD68, CD117, CD34, LCA, CD38, CD79a | The vulva, the vagina and the cervix | 9.0 | PET-CT: A soft tissue mass in the vulva, vagina, and cervix, with irregular shape, unclear border, and with a SUV of 2.4 | The left inguinal region LN | Isolated MS | Chemo (only one cycle) | Died |
Madabhavi et al[10], 2016 | 38 | Vaginal bleeding | No | MPO, CD117, LCA | The vaginal fornix | 5.0 | CT: A mass lesion located in the vagina, mild hepatomegaly, and splenomegaly | The supra and infra diaphragmatic LN | Isolated MS | Chemo, RT | Asymptomatic |
Hu et al[13], 2016 | 45 | Vaginal mass and anuria | HSCT for MDS 7 yr ago | Lysozyme, CD117, CD34, CD56 | The vulva, bilateral adnexae and bilateral perirenal spaces | 2.5 | US: bilateral hydronephrosis with a nondistended bladder; CT/MRI: multiple tumours in the bilateral perirenal spaces and bilateral adnexae with encasement of bilateral ureters | NS | M5 | Chemo | Died |
Present case | 26 | Vaginal bleeding and vaginal mass | No | CD99, CD68, CD15, LAC | The vulva, the vagina and massive infiltration of the pelvic floor | 10.5 | MRI: Ill-defined, irregular, diffuse mass with involvement of the vagina, paravaginal tissue, the urethra, posterior wall of the bladder, the left ischiorectal fossa, the left side of the pelvic diaphragm and the pelvic floor | The bilateral obturator LN | M2 | Chemo, HSCT | CR |
Erşahin et al[17], 2007 | 73 | Vulval swelling and stinking vaginal discharge | Breast lesion since 3-6 yr ago | CD9, CD13, CD15, CD33, HLA-DR | The vulva | 6.0 | NS | NS | M2 | Chemo | Died (breast cancer with multiple metastases) |
Skeete et al[7], 2010 | 36 | Vaginal mass | AML recurred repeatedly since 8 yr ago | CD68 | The vagina and the rectovaginal septum | A large mass | NS | No | AML without subtype | Chemo, RT | Died (leukemic relapse) |
Policarpio-Nicolas et al[16], 2012 | 16 | Vaginal mass | No | Lysozyme, CD117, CD68, CD43, CD34, CD45RB, CD56, tdt | The vulva | 2.0 | NS | The left inguinal LN | Isolated MS | Chemo | CR, 11 mo |
Bao et al[5], 2019 | 53 | Vaginal bleeding and vaginal mass | Uterine fibroids | Lysozyme, CD68, CD43, CD45, CD4, CD163, CD56 | The vagina | 8.0 | NS | NS | Isolated MS | Hysterectomy and resection of vaginal mass, chemo, HSCT | CR |
Zhang et al[1],2019 | 47 | Vaginal ulceration and fever | No | MPO, lysozyme, CD68, CD43, CD38, CD117, Ki-67 | The valva | NS | NS | NS | M2 | Chemo, HSCT | CR, 27 mo |
- Citation: Wang JX, Zhang H, Ning G, Bao L. Vulvovaginal myeloid sarcoma with massive pelvic floor infiltration: A case report and review of literature. World J Clin Cases 2022; 10(23): 8312-8322
- URL: https://www.wjgnet.com/2307-8960/full/v10/i23/8312.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i23.8312